qPCR market to reach $3.3 billion by 2032, driven by demand for personalized medicine

From GlobeNewswire: 2024-11-25 04:30:00

The qPCR Instruments market was valued at USD 1.6 billion in 2023, projected to grow at a CAGR of 8.4% from 2024 to 2032. Increasing focus on personalized medicine and rising disease prevalence are key drivers. qPCR tools are crucial for diagnosing infectious diseases, cancer, and genetic disorders due to their accuracy and speed.

qPCR plays a vital role in personalized medicine by enabling detailed genetic profiling and real-time monitoring. This technology is essential for developing individualized treatments and tailoring therapies to meet patients’ specific needs. As demand for personalized therapies grows, qPCR’s role in drug development and targeted treatments is expanding.

In 2023, the qPCR systems segment led the market at USD 644.2 million. These systems are critical platforms for quantitative analysis in diagnostics, research, and drug development. Despite being capital-intensive, qPCR systems are widely utilized for various applications, making them a key revenue contributor.

The gene expression segment held the largest share in 2023 at 26.6%. Gene expression analysis is crucial in molecular biology, especially in cancer research, drug development, and disease mechanism studies. qPCR instruments are essential for such applications, driving consistent demand.

North America’s qPCR market was USD 621 million in 2023, expected to grow at 8.1% through 2032. The region’s rising incidence of infectious diseases like HIV, influenza, and COVID-19 has increased demand for advanced diagnostic tools. qPCR instruments are instrumental in quickly detecting pathogens, aiding effective disease management.



Read more at GlobeNewswire: qPCR Instruments Market to hit USD 3.3 billion by 2032,